News from Zyme and the companies we work with.
Exonate appoints Dr Rafiq Hasan as Non-Executive Director
Appointment brings extensive experience in global pharma leadership and progressing ophthalmology drugs to market and further strengthens Board Cambridgeshire, UK, 28 May 2024: Exonate Ltd., a biotechnology company developing novel, [...]
Sphere Fluidics appoints Curtis Nicholson as Director of Sales, EMEA, to support accelerated growth in key markets
Cambridge, UK, 23 May, 2024: Sphere Fluidics, a leading provider of innovative microfluidics-based solutions for single-cell analysis and isolation, today announced the appointment of Curtis Nicholson as Director of Sales [...]
Closed Loop Medicine appoints Paul Johnson as Non-Executive Director
Appointment of digital healthcare leader to Board to support the Company as it enters next phase of commercial development Co-founder and former CEO of Lemonaid Health, a leading innovator in [...]
PhoreMost introduces GlueSEEKER platform for discovery of molecular glue degraders
New drug discovery platform integrates computational approaches with molecular biology for development of novel degrader therapeutics Cambridge, UK, 21 May 2024: PhoreMost Ltd., a leading UK biopharmaceutical company unlocking the [...]
ERS Genomics and IRBM sign CRISPR/Cas9 license agreement
License agreement provides IRBM access to CRISPR gene editing technology to be applied across its drug discovery services offering Dublin, Ireland, and Rome, Italy, 20 May 2024: ERS Genomics Limited [...]
Closed Loop Medicine and Pharmanovia commence OptiZest study for their first precision medicine combination therapeutic
Closed Loop Medicine and Pharmanovia commence OptiZest study for their first precision medicine combination therapeutic Proof-of-Concept study to investigate personalized dose management of first-line anti-hypertensive in improving blood pressure [...]
Enhanc3D Genomics appoints Hazel Jones as Chief Executive Officer
Cambridge, UK, 15 May 2024: Enhanc3D Genomics, a company developing disruptive technologies to unlock the 3D genome for use in novel target identification and unique patient stratification, today announced the [...]
Optibrium Partners with FMC Corporation to Transform Agrochemical Discovery
Optibrium’s AI-powered discovery platform Cerella™ chosen by FMC to accelerate its agrochemical discovery pipeline CAMBRIDGE, UK, and PHILIDELPHIA, US, 14 May 2024 – Optibrium, a leading developer of software and [...]
PlaqueTec and the Babraham Institute collaborate on early phase target discovery and development
Campus Innovation Award (CIA)-funded project evaluated lead compounds predicted to bind a pro-inflammatory protein discovered by PlaqueTec Cambridge, UK, 14 May 2024: PlaqueTec, a company identifying endotype-specific biomarkers to advance [...]
ArgusEye closes €2.8 million funding to accelerate bioprocessing
Led by Voima Ventures and co-led by existing investor Eir Ventures Funding will support continued development of Auga sensor system platform to accelerate the bioprocessing workflow from early upstream to [...]
ERS Genomics appoints John E Milad as Chief Executive Officer
Dublin, Ireland, 13 May 2024: ERS Genomics Limited (‘ERS’), the CRISPR licensing company, today announced the appointment of John E Milad as CEO, with immediate effect. John brings over 25 [...]
Broken String Biosciences and the Francis Crick Institute collaborate to advance ALS research
Partnership to expand applications of DNA break-mapping technology and advance understanding of genomic instability in development of the neurodegenerative disease amyotrophic lateral sclerosis Cambridge and London, UK, 07 May 2024: [...]
